Bard® InLay® Versa Fit® Ureteral Stent with HydroGlide™ Guidewire 777600Recalls & reported problems
C. R. Bard, Inc. · INLAY VERSA FIT URETERAL STENT W/HYDROGLIDE GUIDEWIRE · Class 2 · Implant
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10801741014502), received between Jan 23, 2026 and Jan 23, 2026 — classified as 1 injury.
The most frequently reported specific device problem is “Calcified” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Calcified1
Patient problems
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryJan 23, 2026Calcified
IT WAS REPORTED THAT ON (B)(6) 2025, THE PATIENT UNDERWENT PERCUTANEOUS NEPHROSCOPIC LASER LITHOTRIPSY OF THE RIGHT RENAL PELVIS. A RIGHT URETERAL STENT (6F BARD) WAS INSERTED POST-OPERATIVELY TO DILATE THE URETERAL STRICTURE. THE PLAN WAS TO REMOVE THE RIGHT URETERAL STENT THREE MONTHS LATER. ON (B)(6), THE PATIENT CAME TO THE HOSPITAL FOR STENT REMOVAL. AN ABDOMINAL KUB X-RAY REVEALED STONE FORMATION AND ENCRUSTATION ON THE SURFACE OF THE STENT, MAKING REMOVAL DIFFICULT. ON (B)(6), UNDER GENERAL ANESTHESIA, THE PATIENT UNDERWENT RIGHT PERCUTANEOUS NEPHROSCOPIC PNEUMATIC BALLISTIC LITHOTRIPSY AND STENT REMOVAL. THE SURGERY WAS SUCCESSFUL.
Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available
MAUDE report 24171723 ↗
Other STENT, URETERAL devices
- Bard® InLay Optima® Ureteral Stent 788426C. R. Bard, Inc. · STENT, URETERAL1 recall100 reports
- Bard® InLay Optima® Ureteral Stent 788626C. R. Bard, Inc. · STENT, URETERAL122 reports
- Bard® InLay® Ureteral Stent with HydroGlide™ Guidewire 777626C. R. Bard, Inc. · STENT, URETERAL118 reports
- Bard® InLay® Ureteral Stent with HydroGlide™ Guidewire 777426C. R. Bard, Inc. · STENT, URETERAL108 reports
- Bard® InLay® Ureteral Stent 778626C. R. Bard, Inc. · STENT, URETERAL100 reports
- Percuflex™ Plus M0061752530Boston Scientific Corporation · STENT, URETERAL1 death99 reports
- Contour VL™ M0061801560Boston Scientific Corporation · STENT, URETERAL1 recall45 reports
- Polaris™ Ultra M0061921330Boston Scientific Corporation · STENT, URETERAL71 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page